Non-oxime inhibitors of B-Raf(V600E) kinase.
Ren, L., Wenglowsky, S., Miknis, G., Rast, B., Buckmelter, A.J., Ely, R.J., Schlachter, S., Laird, E.R., Randolph, N., Callejo, M., Martinson, M., Galbraith, S., Brandhuber, B.J., Vigers, G., Morales, T., Voegtli, W.C., Lyssikatos, J.(2011) Bioorg Med Chem Lett 21: 1243-1247
- PubMed: 21251822 
- DOI: https://doi.org/10.1016/j.bmcl.2010.12.061
- Primary Citation of Related Structures:  
3PPJ, 3PPK, 3PRF, 3PRI - PubMed Abstract: 
The development of inhibitors of B-Raf(V600E) serine-threonine kinase is described. Various head-groups were examined to optimize inhibitor activity and ADME properties. Several of the head-groups explored, including naphthol, phenol and hydroxyamidine, possessed good activity but had poor pharmacokinetic exposure in mice ...